Coskun, M. D. Et Al. 2020. alpha v beta 3 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model. FRONTIERS IN PHARMACOLOGY , vol.11 .

Coskun, M. D., Sudha, T., Bharali, D. J., ÇELİKLER KASIMOĞULLARI, S., Davis, P. J., & Mousa, S. A., (2020). alpha v beta 3 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model. FRONTIERS IN PHARMACOLOGY , vol.11.

Coskun, Melis Et Al. "alpha v beta 3 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model," FRONTIERS IN PHARMACOLOGY , vol.11, 2020

Coskun, Melis D. Et Al. "alpha v beta 3 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model." FRONTIERS IN PHARMACOLOGY , vol.11, 2020

Coskun, M. D. Et Al. (2020) . "alpha v beta 3 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model." FRONTIERS IN PHARMACOLOGY , vol.11.

@article{article, author={Melis Debreli Coskun Et Al. }, title={alpha v beta 3 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model}, journal={FRONTIERS IN PHARMACOLOGY}, year=2020}